Ajanta Pharma Limited — Moxifloxacin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Moxifloxacin · $1.4M export value · DGFT Verified
Ajanta Pharma Limited is the #5 Indian exporter of Moxifloxacin with $1.4M in export value and 112 verified shipments. Ajanta Pharma Limited holds a 4.2% market share in Moxifloxacin exports across 11 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Moxifloxacin Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Moxifloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $504.1K | 29 | 39.4% |
| FRANCE | $307.1K | 12 | 24.0% |
| UZBEKISTAN | $185.7K | 19 | 14.5% |
| KENYA | $147.5K | 17 | 11.5% |
| SRI LANKA | $48.1K | 9 | 3.8% |
| UGANDA | $34.4K | 8 | 2.7% |
| ZAMBIA | $27.2K | 11 | 2.1% |
| KAZAKHSTAN | $21.9K | 2 | 1.7% |
| KAZAKISTAN | $4.9K | 1 | 0.4% |
| GUINEA | $20 | 1 | 0.0% |
Ajanta Pharma Limited exports Moxifloxacin to 12 countries. The largest destination is IRAQ accounting for 39.4% of Ajanta Pharma Limited's Moxifloxacin shipments, followed by FRANCE (24.0%) and UZBEKISTAN (14.5%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Moxifloxacin from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HAWKARY PHARMACEUITCAL CO.* | IRAQ | $325.9K | 18 |
| PLANET PHARMA SA | FRANCE | $307.1K | 12 |
| HARLEYS LIMITED | KENYA | $147.5K | 17 |
| BRANCH OFFICE AJANTA PHARMA | UZBEKISTAN | $103.8K | 8 |
| KAWKAB SCIENTIFIC BUREAU* | IRAQ | $69.2K | 6 |
| BRANCH OFFICE AJANTA PHARMA MAURITI | UZBEKISTAN | $67.0K | 9 |
| HAWKARY PHARMACEUITCAL CO | IRAQ | $59.0K | 4 |
| KAWKAB SCIENTIFIC BUREAU | IRAQ | $50.0K | 1 |
| A. BAUR AND CO. (PRIVATE) LTD. | SRI LANKA | $26.2K | 5 |
| A BAUR AND CO PRIVATE LIMITED | SRI LANKA | $16.7K | 3 |
Ajanta Pharma Limited supplies Moxifloxacin to 25 buyers globally. The largest buyer is HAWKARY PHARMACEUITCAL CO.* (IRAQ), followed by PLANET PHARMA SA (FRANCE) and HARLEYS LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Moxifloxacin Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $14.3M worth of Moxifloxacin through 2,413 shipments from 336 suppliers to 137 countries, serving 731 buyers globally. Ajanta Pharma Limited contributes $1.4M to this total, accounting for 4.2% of India's Moxifloxacin exports. Ajanta Pharma Limited ships Moxifloxacin to 12 countries through 25 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Moxifloxacin Exports?
Ajanta Pharma Limited's average Moxifloxacin shipment value is $12.4K per consignment, based on 112 shipments totaling $1.4M. The largest destination is IRAQ (39.4% of Ajanta Pharma Limited's Moxifloxacin exports).
How Does Ajanta Pharma Limited Compare to Other Indian Moxifloxacin Exporters?
Ajanta Pharma Limited ranks #5 among 336 Indian Moxifloxacin exporters with a 4.2% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($2.3M), MICRO LABS LIMITED ($2.3M), EUGIA PHARMA SPECIALITIES LIMITED ($1.9M). Ajanta Pharma Limited processed 112 shipments to 11 destination countries.
What Moxifloxacin Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| APDROPS EYE DROPS[MOXIFLOXACIN HYDROCHLO | $123.5K | 7 |
| APDROPS EYE DROPS[MOXIFLOXACIN HYDROCHLORIDE EYE DROPS 0.5W/V][37350 X 1 = 37350BOTTLES]CONT:AS PER INVOICENOS | $67.0K | 3 |
| APDROPS DX EYE DROPS 3ML [22600 X 1 = 22600 BOTTLES] [MOXIFLOXACIN AND DEXAMETHASONE EYE DROPS] CONT AS PER INVOICE | $60.3K | 3 |
| APDROPS DX EYE DROPS 5ML 37450x1 37450 BTL MOXIFLOXACIN WITH DEXAMETHASONE EYEDROPS EACH ML MOXIFLOXACIN AS PER INV | $50.0K | 1 |
| SHIPMENT UNDER CONSIGNMENT SALE:APDROPSEYE DROPS[MOXIFLOXACIN HYDROCHLORIDE EYEDROPS 0.5W/V][55050x1=55050 BOTTLES] | $50.0K | 1 |
| APDROPS DX EYE DROPS 5ML[24323X1=24323 BTL][MOXIFLOXACIN AND DEXAMETHASONE OPHTHALMIC SOLUTION]EACH ML CONT:AS PER INV | $50.0K | 1 |
| APDROPS DX EYE DROPS 3ML [30280 X 1 = 30280 BOTTLES] [MOXIFLOXACIN AND DEXAMETHASONE EYE DROPS] CONT AS PER INVOICE | $50.0K | 1 |
| APDROPS DX EYE DROPS 3ML[23000x 1 = 23000 BOTTLES][MOXIFLOXACIN AND DEXAMETHASONE EYE DROPS][EACH ML CONT:AS PER INVOICE | $50.0K | 1 |
| APDROPS DX EYE DROPS 5ML[18022x1=18022 BTL][MOXIFLOXACIN AND DEXAMETHASONE OPHTHALMIC SOLUTION]EACH ML CONT:AS PER INV | $44.8K | 3 |
| APDROPS DX EYE DROPS 5ML[16250X1=16250 BTL][MOXIFLOXACIN AND DEXAMETHASONE OPHTHALMIC SOLUTION]EACH ML CONT:AS PER INV | $41.4K | 1 |
Ajanta Pharma Limited exports 88 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APDROPS EYE DROPS[MOXIFLOXACIN HYDROCHLO with 7 shipments worth $123.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Ajanta Pharma Limited Compare to Nearest Moxifloxacin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | MICRO LABS LIMITED | $2.3M | 86 | 14 | $26.5K |
| 3 | EUGIA PHARMA SPECIALITIES LIMITED | $1.9M | 39 | 1 | $50.0K |
| 5 | AJANTA PHARMA LIMITED ★ | $1.4M | 112 | 11 | $12.4K |
| 1 | MACLEODS PHARMACEUTICALS LTD | $1.4M | 27 | 14 | $50.0K |
| 6 | MYLAN LABORATORIES LIMITED | $1.0M | 28 | 4 | $36.8K |
Ajanta Pharma Limited ranks #5 among 336 Indian Moxifloxacin exporters. Average shipment value of $12.4K compared to the market average of $42.4K. The closest competitors by value are MICRO LABS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Moxifloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 311 | 12.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 263 | 10.9% |
| DELHI AIR CARGO ACC (INDEL4) | 152 | 6.3% |
| DELHI AIR | 132 | 5.5% |
| NHAVA SHEVA SEA (INNSA1) | 126 | 5.2% |
| Bombay Air | 119 | 4.9% |
| CHENNAI AIR | 111 | 4.6% |
| CHENNAI AIR CARGO ACC (INMAA4) | 93 | 3.9% |
What Other Advanced Antibiotics Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Moxifloxacin Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Moxifloxacin, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 112 individual customs records matching Ajanta Pharma Limited exporting Moxifloxacin, covering 88 formulations to 12 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Moxifloxacin Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Moxifloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Moxifloxacin Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Moxifloxacin. For current shipment-level data, contact TransData Nexus.